Dr. Haim Belinson

My research focus and interest has been disorders that effect human behavior. As such, my MSc and PhD I have focused on risk factor in Alzheimers disease and my postdoctoral research on the study of autism spectrum disorder. In 2016, I joined the Pharmacology Department at Teva pharmaceutical, and was responsible for evaluation and support of non-clinical pharmacology projects relating to various CNS and pain indications. I gained significant experience in numerous projects and at different stages of development, ranging from ideation to late development and life cycle management. Currently, I am heading the developmental progress of Bsense Bio Therapeutics, a biotech company supported by the accelerator FutuRx. Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety. My broad knowledge and technical expertise acquired in multiple indications and across various disorders of the CNS provide me with the appropriate tools for assessment, evaluation and supervision of a well thought out, meaningful and successful project.